# |
Name |
|
Stock Price |
Change |
Price (30 days) | 52W low/high | Sector |
---|
The Clinical Trials company in Sweden with the highest Revenue is Swedish Orphan Biovitrum AB (publ) (Stockholm Stock Exchange: SOBI.ST) at USD 2.34 B.
The Clinical Trials company in Sweden with the lowest Revenue is Modus Therapeutics Holding AB (publ) (Stockholm Stock Exchange: MODTX.ST) at 0.0.
The top 10 Clinical Trials companies in Sweden by Revenue are Swedish Orphan Biovitrum AB (publ), Elekta AB (publ), Arjo AB (publ), Vimian Group AB (publ), Vitrolife AB (publ), Camurus AB (publ), RaySearch Laboratories AB (publ), Surgical Science Sweden AB (publ), Xvivo Perfusion AB (publ) and CellaVision AB (publ).
The bottom 10 Clinical Trials companies in Sweden by Revenue are Modus Therapeutics Holding AB (publ), Lipum AB (publ), Infant Bacterial Therapeutics AB (publ), Guard Therapeutics International AB (publ), Isofol Medical AB (publ), Cantargia AB (publ), Aptahem AB (publ), Ascelia Pharma AB (publ), AlzeCure Pharma AB (publ) and SynAct Pharma AB.